Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models (journal article) Molecular Cancer Therapeutics, volume 19, issue 1, pages 292-303 (2020). |
Journal of Biological Chemistry, volume 291, issue 11, pages 5986-5996 (2016). |
Journal of Medicinal Chemistry, volume 58, issue 12, pages 5121-5136 (2015). |
Systems-wide Analysis of K-Ras, Cdc42, and PAK4 Signaling by Quantitative Phosphoproteomics (journal article) Molecular & Cellular Proteomics, volume 12, issue 8, pages 2070-2080 (2013). |
JNCI: Journal of the National Cancer Institute, volume 105, issue 9, pages 606-607 (2013). |
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes (journal article) PLoS ONE, volume 7, issue 5, pages e36402- (2012). |
p21-activated kinase 1: PAK'ed with potential (journal article) Oncotarget, volume 2, issue 6, pages 491-496 (2011). |
Proceedings of the National Academy of Sciences, volume 108, issue 17, pages 7177-7182 (2011). |
In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models (journal article) Clinical Cancer Research, volume 15, issue 14, pages 4649-4664 (2009). |
Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab (journal article) Clinical Cancer Research, volume 15, issue 12, pages 4147-4156 (2009). |